Vytisknout
0477882 - ÚI 2018 US eng J - Článek v odborném periodiku
Soukup, T. - Doseděl, M. - Nekvindová, J. - Kuběna, A.A. - Tachecí, I. - Duintjer Tebbens, Jurjen - Vlček, J. - Bradna, P. - Barvík, I. - Pávek, P.
The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.
Pharmacogenetics and Genomics. Roč. 27, č. 2 (2017), s. 43-50. ISSN 1744-6872. E-ISSN 1744-6880
Klíčová slova: modifying antirheumatic drugs * methylenetetrahydrofolate reductase * eular recommendations * a1298c polymorphisms * induced nodulosis * common mutation * 2013 update * risk-factor * adenosine * disease * adenosine and folate pathways * methotrexate * nodules * pharmacogenetics * rheumatoid arthritis
Kód oboru RIV: FR - Farmakologie a lékárnická chemie
Impakt faktor: 2.250, rok: 2017
Trvalý link: http://hdl.handle.net/11104/0274101
Soukup, T. - Doseděl, M. - Nekvindová, J. - Kuběna, A.A. - Tachecí, I. - Duintjer Tebbens, Jurjen - Vlček, J. - Bradna, P. - Barvík, I. - Pávek, P.
The plausible association of MTHFR and ADORA2A polymorphisms with nodules in rheumatoid arthritis patients treated with methotrexate.
Pharmacogenetics and Genomics. Roč. 27, č. 2 (2017), s. 43-50. ISSN 1744-6872. E-ISSN 1744-6880
Klíčová slova: modifying antirheumatic drugs * methylenetetrahydrofolate reductase * eular recommendations * a1298c polymorphisms * induced nodulosis * common mutation * 2013 update * risk-factor * adenosine * disease * adenosine and folate pathways * methotrexate * nodules * pharmacogenetics * rheumatoid arthritis
Kód oboru RIV: FR - Farmakologie a lékárnická chemie
Impakt faktor: 2.250, rok: 2017
Trvalý link: http://hdl.handle.net/11104/0274101